Tuberculosis and Respiratory Diseases (TRD) gives priority to high-quality academic experimental or clinical research that will contribute to the development of knowledge of the etiology, diagnosis and treatment of tuberculosis and respiratory diseases. Manuscripts types include original articles, reviews, images of interest, editorials, and letters to the editor. The journal is issued on the first day of the January, April, July, and October.
All work must conform to the ethical guidelines specified on Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org/).
Research involving human subjects must conform to the ethical guidelines specified by the Helsinki Declaration of 1975 (revised 2013;https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/). It is recommended that any research dealing with a clinical trial be registered with a primary national clinical trial registration site such as https://cris.nih.go.kr/cris/index.jsp, or other sites accredited by the WHO or the International Committee of Medical Journal Editors. The relevant studies must have been approved by the Institutional Ethics Board or Institutional Review Board of each institution. It should also be noted, where applicable, that study subjects provided written informed consent. In cases of animal experimental studies, the experimental procedure must conform to the guidelines of the Institutional Ethics Board or those specified on the NIH Guide for the Care and Use of Laboratory Animals. The editorial board reserves the right to require authors to submit copies of informed consent forms and a letter of the approval signed by the Institutional Ethics Board, if applicable.
All authors are required to upload disclosure forms when their manuscript is submitted to the Journal. Please upload these forms along with your other manuscript files, choosing File Designation: "Disclosure of Financial Interest Form(S)." Disclosure form shall be same with ICMJE Uniform Disclosure Form for Potential Conflicts of Interest (http://www.icmje.org/coi_disclosure.pdf). When a manuscript is accepted for publication, TRD will determine the part(s) of an author's disclosure that will be published with the manuscript.
In accordance with the ICMJE recommendations defining the role of authors, authorship should be based on all four of the following criteria. Please see the ICMJE Recommendations (http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html) for more information.
The submitted manuscript should be original and should not either had been published or submitted to other scientific journals at the same time. In addition, part or all of the accepted manuscript should not be duplicated in other scientific journals without the permission of the editorial committee. The submitted manuscript will be evaluated for possible plagiarism or duplicated publication by CrossCheck upon arrival. If plagiarism or duplicate publications related to the paper of this journal are detected, these issues will be announced in the journal, the institute of the authors will be informed and penalties will be imposed on the authors. It is mandatory for authors to resolve any copyright issues when citing a figure or table from other journals which are not open access.
With regard to all matters associated with research ethics, such as ethical guidelines and plagiarism/duplicate publication/scientific misconduct, the review and processing procedures are based on 'Good Publication Practice Guidelines for Medical Journals' (https://www.kamje.or.kr/board/view?b_name=bo_publication&bo_id=7) and 'Guidelines on Good Publication' (https://publicationethics.org/guidance/Guidelines).
For clinical trials, authors are required to provide a Data Sharing Statement if data will be shared or not. The Data Sharing Statement form can be downloaded here. The authors are required to fill in a Data Sharing Statement form. Data Sharing Statement should be submitted along with the manuscript. Authors will be asked how the data will be available and if there will be any restrictions on the use. Authors also have the option to explain why data may not be shared. The Data Sharing Statement will be published online alongside the article.
All manuscripts must be submitted at the TRD e-submission website, http://mc04.manuscriptcentral.com/trd. Only manuscripts submitted through the web site will be considered for review.
The editorial office checks the paper’s composition and arrangement against the journal’s Author Guidelines to make sure it includes the required sections and stylizations. The editor-in-chief and deputy editors check that the paper is appropriate for the journal and is sufficiently original and interesting. Then, the deputy editors and associate editors handle the peer review process. At this stage, the paper may be rejected without being reviewed any further.
The selected manuscripts are reviewed by single-blind peer review. The handling editors send invitations to individuals he or she believes would be appropriate reviewers. As responses are received, further invitations are issued, if necessary, until the required number of acceptances is obtained – minimum number of peer-reviewers is two.
Upon completion of the review, notification of acceptance or rejection will be sent to the corresponding author by e-mail. If a revised version is requested, it should be returned no later than 90 days after notification.
All materials must be written in clear, appropriate English. The manuscript must be written in 12-point font with double-line spacing and at least 2.5-cm margins on A4 size paper using Microsoft Word.
All pages should be numbered consecutively starting with the title page as page 1. Line numbers (i.e., 1, 2, 3 etc.) should be displayed in the left-hand margin of the manuscript file. Line numbering can be added from the File/Page Setup menu of word processing programs and should be continuous throughout the manuscript file. Do not restart numbering from each page.
A. Original Articles
The total length should not exceed 5,000 words (excluding the abstract, references, and table/figure legends). The total number of tables and figures should be fewer than 10.
Manuscripts should begin with the title page followed by an Abstract and Keywords, Introduction, Materials and Methods, Results, Discussion, Conflicts of Interest, Acknowledgements, References (up to 40 references), Tables and/or Figures.
Acronyms should be avoided where possible. Where a complex or cumbersome term or phrase is repeatedly used, however, it should be abbreviated, preferably using standard abbreviations. The abbreviation should be appear in parentheses following the first use of the term or phrase and can then be used in the remainder of the text.
Human names, regional names and other proper nouns should be used in their original form. Arabic numerals should be used. Laboratory measurements should be expressed in SI (Standard International) units. A single space is usually required between the numeral and the unit; no space is inserted for % and ℃.
B. Review Articles
Review articles are generally prepared in the same format as original articles, but the details of manuscript format may be flexible according to the contents. They are organized as follows: title page, abstract and keywords, introduction, body text, conclusion, conflict of interests, acknowledgments, references, tables, and figure legends. There should be an unstructured abstract equal to or less than 250 words. The length of the text excluding references, tables, and figures should not exceed 5,000 words, with up to 100 references.
A Review article should be invited by the Editor of TRD. Uninvited review may not be approved for the submission. Please contact the editorial office if you plan to submit an uninvited review.
C. Images of Interest
Original, high-quality images are considered for publication (subject to editing and abridgment). There should be no more than two figures and five authors and they should not exceed 300 words in total, with up to 10 references. An abstract is not required.
D. Editorials
Editorials are invited by the Editor-in-Chief and should be commentaries on original articles published in the same issue of the Journal. Editorials should not exceed 1,000 words (excluding references, tables, and figures) and contain no more than 15 references. An abstract is not required.
E. Letters to the Editor
Letter to the Editor can be published through review and approval by the editors when its scientific quality is acceptable and space in the TRD is available. A Letter to the Editor should be concise and no longer than 1,000 words. It should have a title, distinct from the title of the referenced article, an unstructured main content, and a list of references which should be no more than 10. Only one table or figure would be accepted. An abstract is not required.
Authors are encouraged to prepare original articles according to the EQUATOR research reporting guidelines, as listed below.
Study Type | Guideline |
Randomized controlled trial | CONSORT (CONsolidated Standards Of Reporting Trials) |
Nonrandomized design | TREND (Transparent Reporting of Evaluations with Nonrandomized Designs) |
Observational studies in Epidemiology | STROBE (STrengthening the Reporting of Observational studies in Epidemiology) |
Diagnostic accuracy study | STARD (STAndards for Reporting of Diagnostic Accuracy Studies) |
Systematic review or meta-analysis | PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) |
Animal research | ARRIVE Guidelines |
Clinical practice guideline | RIGHT Guidelines |
Prediction Model Development and Validation | TRIPOD Guidelines |
https://www.equator-network.org/reporting-guidelines/
The charge for publication is 3,500 KRW per page for Review Article, Original Articles, and Images of Interest. Editorials, Letters to the Editor/Author Replies, and Invited Review Articles are not subject to article processing charges.
A charge of 10,000 KRW per color figure will apply. And authors will be charged an additional fee for color prints or reprints. The charge is 138,000 KRW for a single page in color print and 276,000 KRW for two or more pages in color print. Offprints may be purchased if ordered at the proof stage. The offprint charge is 300 KRW per offprint, 5,000 KRW for domestic shipping, and 70,000 KRW for overseas shipping.
Open access policy
Tuberculosis and Respiratory Diseases is an open access journal. Articles are distributed under the terms of the Creative Commons Attribution Non-commercial license, which permits unrestricted use, distribution, and reproduction in any medium except commercial use, provided the original work is properly cited. For commercial purposes, the process of permission request to the Editorial Office of Tuberculosis and Respiratory Diseases is mandatory. This is in accordance with the Budapest Open Access Initiative definition of open access.
It also follows the open access policy of PubMed Central at United States National Library of Medicine (http://www.ncbi.nlm.nih.gov/pmc/).
All the content of the journal is available immediately upon publication without embargo period.
Archiving policy
Full text of Tuberculosis and Respiratory Diseases has been archived in PubMed Central (PMC)/Europe PMC/PMC Canada (http://www.ncbi.nlm.nih.gov/pmc/journals/1922) from the Volume 72, Number 3, 2012.
Deposit policy (Self-archiving policy) according to Sherpa/Romeo (http://www.sherpa.ac.uk/)
Author cannot archive pre-print (i.e. pre-refereeing). Author can archive post-print (i.e. final draft post-refereeing). Author can archive publisher's version/PDF.
Detailed description of use of articles of Tuberculosis and Respiratory Diseases
Representing all authors, corresponding author needs to sign a copyright transfer form electronically at the time of submission. A copyright transfer form is available at the TRD e-submission website, http://mc04.manuscriptcentral.com/trd.
Tuberculosis and
Respiratory Diseases
Print ISSN: 1738-3536
Online ISSN: 2005-6184